SCHEMBL5076199

SCHEMBL5076199

CN1CCC(O)[C@H]1C(=O)O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.36
ALDH1A1 P00352 1/20 0.35
TSHR P16473 2/20 0.32
GBA1 P04062 1/20 0.32
GABRP O00591 1/20 0.31
GABRD O14764 1/20 0.31
GABRA1 P14867 1/20 0.31
GABRB1 P18505 1/20 0.31
GABRG2 P18507 1/20 0.31
GABRB3 P28472 1/20 0.31
GABRA5 P31644 1/20 0.31
GABRA3 P34903 1/20 0.31
GABRA2 P47869 1/20 0.31
GABRB2 P47870 1/20 0.31
GABRA4 P48169 1/20 0.31
GABRE P78334 1/20 0.31
PMP22 Q01453 1/20 0.31
GABRA6 Q16445 1/20 0.31
GABRG1 Q8N1C3 1/20 0.31
GABRG3 Q99928 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17795772 1.00 TDP1 (0.36) TDP1ALDH1A1TSHRGBA1GABRP
SCHEMBL4648895 1.00 TDP1 (0.36) TDP1ALDH1A1TSHRGBA1GABRP
SCHEMBL4895931 1.00 TDP1 (0.36) TDP1ALDH1A1TSHRGBA1GABRP
SCHEMBL204261 1.00 TDP1 (0.36) TDP1ALDH1A1TSHRGBA1GABRP
Hydrochloric Acid SCHEMBL143429 0.98 TDP1 (0.39) TDP1ALDH1A1TSHRGBA1GABRP
SCHEMBL10076954 0.84 GBA1 (0.31) TDP1GBA1
SCHEMBL21515903 0.84 GBA1 (0.31) TDP1GBA1
SCHEMBL21514826 0.84 GBA1 (0.31) TDP1GBA1
SCHEMBL16845501 0.82 SMN1; SMN2 (0.35) GBA1SMN1; SMN2
SCHEMBL26431341 0.82 GBA1 (0.30) TSHRGBA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025123045-A1 PREDICTIVE AND DIAGNOSTIC SCREENING METHODS FOR ENDOMETRIAL CANCER ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) 2025-06-12 WO claimed
US-20250147048-A1 METHODS OF DIAGNOSTIC SCREENING AND EARLY DETECTION OF ADENOMYOSIS ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA 2025-05-08 US claimed
WO-2005065675-A1 METHOD OF TREATMENT PREMACS INTERNATIONAL PTY. LTD. (AU) 2005-07-21 WO claimed
US-5665371-A SIDE EFFECT REDUCTION HOERRMANN WILHELM (DE) 1997-09-09 US claimed
WO-2025123045-A1 PREDICTIVE AND DIAGNOSTIC SCREENING METHODS FOR ENDOMETRIAL CANCER ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) 2025-06-12 WO disclosed
US-20250147048-A1 METHODS OF DIAGNOSTIC SCREENING AND EARLY DETECTION OF ADENOMYOSIS ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA 2025-05-08 US disclosed
WO-2024015934-A2 METHODS OF DIAGNOSTIC SCREENING AND EARLY DETECTION OF ADENOMYOSIS ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) 2024-01-18 WO disclosed
US-20220102000-A1 PREDICTING BLOOD METABOLITES YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2022-03-31 US disclosed
CN-112546244-A Fibroblast growth factor receptor2 specific peptide reagents and methods 密执安州立大学董事会 2021-03-26 CN disclosed
CN-111107881-A Fibroblast growth factor receptor2 specific peptide reagents and methods 密执安州立大学董事会 2020-05-05 CN disclosed
US-20080125319-A1 Treatment of plants and plant propagation materials with an antioxidant to improve plant health and/or yield MONSANTO TECHNOLOGY, LLC (US) 2008-05-29 US disclosed
WO-2005065675-A1 METHOD OF TREATMENT PREMACS INTERNATIONAL PTY. LTD. (AU) 2005-07-21 WO disclosed
EP-0311193-B1 Antifungal fermentation product MERCK & CO INC (US) 1993-12-01 EP disclosed
EP-0359529-B1 METHOD FOR THE CONTROL OF PNEUMOCYSTIS CARINII MERCK & CO. INC. (US) 1993-03-03 EP disclosed
US-5166135-A Administering cyclohexapeptide antibiotic; AIDS MERCK & COMPANY, INC. (US) 1992-11-24 US disclosed
US-4968608-A CYCLIC PEPTIDE ANTIBIOTIC FROM ZALERION MERCK & CO., INC. (US) 1990-11-06 US disclosed
US-4931352-A Antifungal fermentation product MERCK & CO., INC. (US) 1990-06-05 US disclosed
EP-0359529-A1 Method for the control of pneumocystis carinii MERCK & CO. INC. (US) 1990-03-21 EP disclosed
EP-0311194-A2 Process for antifungal fermentation product and culture MERCK & CO. INC. (US) 1989-04-12 EP disclosed
EP-0311193-A2 Antifungal fermentation product MERCK & CO. INC. (US) 1989-04-12 EP disclosed